SEARCH

SEARCH BY CITATION

REFERENCES

  • Buyse IM, Fang P, Hoon KT, Amir RE, Zoghbi HY, Roa BB. 2000. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet 67:14281436.
  • Chillon M, Casals T, Gimenez J, Ramos MD, Palacio A, Morral N, Estivill X, Nunes V. 1994. Analysis of the CFTR gene confirms the high genetic heterogeneity of the Spanish population: 43 mutations account for only 78% of CF chromosomes. Hum Genet 93:447451.
  • Choy YS, Dabora SL, Hall F, Ramesh V, Niida Y, Franz D, Kasprzyk-Obara J, Reeve MP, Kwiatkowski DJ. 1999. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet 63:383391.
  • Collins FS, Riordan JR, Tsui LC. 1990. The cystic fibrosis gene: isolation and significance. Hosp Pract (Off Ed) 25:4757.
  • Cotton RG, Bray PJ. 2001. Using CCM and DHPLC to detect mutations in the glucocorticoid receptor in atherosclerosis: a comparison. J Biochem Biophys Methods 47:91100.
  • Cremonesi L, Carrera P, Cardillo E, Fumagalli A, Lucchiari S, Ferrari M, Righetti SC, Righetti PG, Gelfi C. 1998. Optimized detection of DNA point mutations by double gradient denaturing gradient gel electrophoresis. Clin Chem Lab Med 36:959961.
  • Dequeker E, Cuppens H, Dodge J, Estivill X, Goossens M, Pignatti PF, Scheffer H, Schwartz M, Schwarz M, Tummler B, Cassiman JJ. 2000. Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis. Eur J Hum Genet Suppl 2:S224.
  • Erlandson A, Stibler H, Kristiansson B, Wahlstrom J, Martinsson T. 2000. Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients. Genet Test 4:293297.
  • Estivill X. 1996. Complexity in a monogenic disease. Nat Genet 12:348350.
  • Estivill X, Bancells C, Ramos C. 1997. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The biomed CF mutation analysis consortium. Hum Mutat 10:135154.
  • Giunta C, Steinmann B. 2000. Characterization of 11 new mutations in COL3A1 of individuals with Ehlers-Danlos syndrome type IV: preliminary comparison of RNase cleavage, EMC and DHPLC assays. Hum Mutat 16:176177.
  • Glavacč D, Ravnik-Glavač M, Potoènik U, Dean M, Wine JJ. 2000. Screening methods for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in non-human primates. Pflugers Arch 439(Suppl 3):R12R13.
  • Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. 2001. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 3:149154.
  • Grody WW, Desnick RJ. 2001. Cystic fibrosis population carrier screening: here at last—are we ready? Genet Med 3:8790.
  • Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M. 1999. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 105:7278.
  • Jones AC, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP, O’Donovan MC. 1999. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 45:11331140.
  • Jones AC, Sampson JR, Hoogendoorn B, Cohen D, Cheadle JP. 2000. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Hum Genet 106:663668.
  • Jones CT, McIntosh I, Keston M, Ferguson A, Brock DJ. 1992. Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum Mol Genet 1:1117.
  • Kaler SG, Devaney JM, Pettit EL, Kirshman R, Marino MA. 2000. Novel method for molecular detection of the two common hereditary hemochromatosis mutations. Genet Test 4:125129.
  • Lam CW, Sin SY, Lau ET, Lam YY, Poon P, Tong SF. 2000. Prenatal diagnosis of glycogen storage disease type 1b using denaturing high performance liquid chromatography. Prenat Diagn 20:765768.
  • Le Marechal C, Audrezet MP, Quere I, Raguenes O, Langonne S, Ferec C. 2001. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum Genet 108:290288.
  • Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN, James CD. 1998. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 26:13961400.
  • Macek Jr M, Mackova A, Hamosh A, Hilman BC, Selden RF, Lucotte G, Friedman KJ, Knowles MR, Rosenstein BJ, Cutting GR. 1997. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet 60:11221127.
  • Mennuti MT, Thomson E, Press N. 1999. Screening for cystic fibrosis carrier state. Obstet Gynecol 93:456461.
  • National Institutes of Health Consensus Development Conference. 1999. Statement on genetic testing for cystic fibrosis. Arch Intern Med 159:15291539.
  • Nickerson ML, Warren MB, Zbar B, Schmidt LS. 2001. Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods. Hum Mutat 17:210219.
  • Ravnik-Glavač M, Glavač D, Dean M. 1994. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Genet 3:801807.
  • Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:10661073.
  • Santer R, Rischewski J, Block G, Kinner M, Wendel U, Schaub J, Schneppenheim R. 2000. Molecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients. Hum Mutat 16:177.
  • Underhill PA, Jin L, Lin AA, Mehdi SQ, Jenkins T, Vollrath D, Davis RW, Cavalli-Sforza LL, Oefner PJ. 1997. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 7:9961005.
  • van der Loop FT, Heidet L, Timmer ED, van den Bosch BJ, Leinonen A, Antignac C, Jefferson JA, Maxwell AP, Monnens LA, Schroder CH, Smeets HJ. 2000. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 58:18701875.
  • Vidaud M, Fanen P, Martin J, Ghanem N, Nicolas S, Goossens M. 1990. Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. Hum Genet 85:446449.
  • Xiao W, Oefner PJ. 2001. Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439474.
  • Zielenski J, Rozmahel R, Bozon D, Kerem B, Grzelczak Z, Riordan JR, Rommens J, Tsui LC. 1991. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10:214228.